During the last session, Entero Therapeutics Inc (NASDAQ:ENTO)’s traded shares were 0.14 million, with the beta value of the company hitting 0.84. At the end of the trading day, the stock’s price was $0.48, reflecting an intraday gain of 3.15% or $0.01. The 52-week high for the ENTO share is $2.29, that puts it down -377.08 from that peak though still a striking 60.42% gain since the share price plummeted to a 52-week low of $0.19. The company’s market capitalization is $2.31M, and the average intraday trading volume over the past 10 days was 0.61 million shares, and the average trade volume was 1.53 million shares over the past three months.

Entero Therapeutics Inc (NASDAQ:ENTO) trade information

Entero Therapeutics Inc (ENTO) registered a 3.15% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 3.15% in intraday trading to $0.48, hitting a weekly high. The stock’s 5-day price performance is -15.09%, and it has moved by 17.89% in 30 days. Based on these gigs, the overall price performance for the year is -76.60%. The short interest in Entero Therapeutics Inc (NASDAQ:ENTO) is 1.24 million shares and it means that shorts have 0.44 day(s) to cover.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 82.03%.

ENTO Dividends

Entero Therapeutics Inc is due to release its next quarterly earnings on 2025-Apr-01. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Entero Therapeutics Inc (NASDAQ:ENTO)’s Major holders

Entero Therapeutics Inc insiders own 7.30% of total outstanding shares while institutional holders control 2.97%, with the float percentage being 3.20%.